These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 10825920)
1. New drugs for allergic conjunctivitis. Med Lett Drugs Ther; 2000 May; 42(1077):39-40. PubMed ID: 10825920 [No Abstract] [Full Text] [Related]
2. Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. The Deutsche Rhinitis-Studiengruppe. Kremer B; Tündermann A; Goldschmidt O Arzneimittelforschung; 1998 Sep; 48(9):924-30. PubMed ID: 9793620 [TBL] [Abstract][Full Text] [Related]
9. Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate. Williams JI; Gow JA; Klier SM; McCue SL; Salapatek AM; McNamara TR Curr Med Res Opin; 2010 Oct; 26(10):2329-38. PubMed ID: 20735291 [TBL] [Abstract][Full Text] [Related]
10. [Second generation topical antihistaminics]. Pietrzkowicz M; Grzelewska-Rzymowska I Pol Merkur Lekarski; 1999 May; 6(35):277-80. PubMed ID: 10437402 [TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of allergic disease. Morris EC Prim Care; 1987 Sep; 14(3):605-21. PubMed ID: 2890178 [TBL] [Abstract][Full Text] [Related]
12. [New drugs in the treatment of respiratory allergic diseases]. Gani F; Senna G; Crivellaro M; Dama A; Castellani L; Mezzelani P Recenti Prog Med; 1997; 88(7-8):333-41. PubMed ID: 9324703 [TBL] [Abstract][Full Text] [Related]
13. Bepotastine besilate for the treatment of pruritus. Bielory L; Duttachoudhury S; McMunn A Expert Opin Pharmacother; 2013 Dec; 14(18):2553-69. PubMed ID: 24191914 [TBL] [Abstract][Full Text] [Related]
14. [H1-receptor antagonists as antiallergy drug agents (a review)]. Gushchin IS Ter Arkh; 1997; 69(10):27-34. PubMed ID: 9471785 [No Abstract] [Full Text] [Related]
15. Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends. Ben-Eli H; Solomon A Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):411-416. PubMed ID: 30020258 [TBL] [Abstract][Full Text] [Related]
16. OTC Products: Alaway and Zaditor. Brahmbhatt Y; Lee KW J Am Pharm Assoc (2003); 2007; 47(6):e27-8. PubMed ID: 18032127 [No Abstract] [Full Text] [Related]
17. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms. Ahluwalia P; Anderson DF; Wilson SJ; McGill JI; Church MK J Allergy Clin Immunol; 2001 Sep; 108(3):449-54. PubMed ID: 11544467 [TBL] [Abstract][Full Text] [Related]
18. Ocular tolerability and safety of ketotifen fumarate ophthalmic solution. Abelson MB; Chapin MJ; Kapik BM; Shams NB Adv Ther; 2002; 19(4):161-9. PubMed ID: 12431041 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population. Abelson MB; Ferzola NJ; McWhirter CL; Crampton HJ Pediatr Allergy Immunol; 2004 Dec; 15(6):551-7. PubMed ID: 15610370 [TBL] [Abstract][Full Text] [Related]
20. Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis. Gonzalez-Estrada A; Reddy K; Dimov V; Eidelman F Expert Opin Pharmacother; 2017 Aug; 18(11):1137-1143. PubMed ID: 28656804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]